Chevron Valuation
Is CVXCL undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CVXCL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CVXCL (CLP146000) is trading below our estimate of fair value (CLP227542.54)
Significantly Below Fair Value: CVXCL is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CVXCL?
Key metric: As CVXCL is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is CVXCL's PE Ratio? | |
|---|---|
| PE Ratio | 17.5x |
| Earnings | US$16.68b |
| Market Cap | US$291.33b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.6x |
| Enterprise Value/EBITDA | 8x |
| PEG Ratio | 2.4x |
Price to Earnings Ratio vs Peers
How does CVXCL's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 10.4x | ||
SHEL Shell | 12.8x | 4.8% | UK£157.7b |
857 PetroChina | 5.8x | -3.8% | HK$1.5t |
XOM Exxon Mobil | 15.3x | 5.2% | US$518.5b |
TTE TotalEnergies | 7.7x | 0.09% | €123.4b |
CVXCL Chevron | 17.5x | 7.4% | CL$291.3b |
Price-To-Earnings vs Peers: CVXCL is expensive based on its Price-To-Earnings Ratio (17.5x) compared to the peer average (10.4x).
Price to Earnings Ratio vs Industry
How does CVXCL's PE Ratio compare vs other companies in the Global Oil and Gas Industry?
| 30 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 30 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: CVXCL is expensive based on its Price-To-Earnings Ratio (17.5x) compared to the Global Oil and Gas industry average (10.6x).
Price to Earnings Ratio vs Fair Ratio
What is CVXCL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 17.5x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CVXCL's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | CL$146,000.00 | CL$169,564.23 +16.1% | 6.3% | CL$189,699.02 | CL$150,585.82 | n/a | 23 |
| Nov ’25 | CL$146,000.00 | CL$162,586.16 +11.4% | 7.2% | CL$184,473.60 | CL$139,316.00 | n/a | 23 |
| Oct ’25 | CL$146,000.00 | CL$153,952.79 +5.4% | 7.4% | CL$175,990.36 | CL$134,686.50 | n/a | 22 |
| Sep ’25 | CL$146,000.00 | CL$163,924.36 +12.3% | 8.6% | CL$189,569.65 | CL$142,408.42 | n/a | 22 |
| Aug ’25 | CL$146,000.00 | CL$173,214.10 +18.6% | 8.6% | CL$196,159.38 | CL$147,595.65 | n/a | 22 |
| Jul ’25 | CL$147,090.00 | CL$172,039.46 +17.0% | 8.0% | CL$192,772.74 | CL$145,047.45 | n/a | 22 |
| Jun ’25 | CL$147,090.00 | CL$164,108.15 +11.6% | 8.0% | CL$183,531.58 | CL$138,094.15 | n/a | 23 |
| May ’25 | CL$147,090.00 | CL$174,794.80 +18.8% | 8.3% | CL$197,312.98 | CL$141,758.84 | n/a | 24 |
| Apr ’25 | CL$147,090.00 | CL$174,360.27 +18.5% | 6.8% | CL$196,980.00 | CL$145,765.20 | n/a | 23 |
| Mar ’25 | CL$147,090.00 | CL$172,954.66 +17.6% | 7.0% | CL$190,394.40 | CL$143,767.20 | n/a | 25 |
| Feb ’25 | CL$129,890.00 | CL$161,521.97 +24.4% | 6.8% | CL$177,260.71 | CL$135,229.82 | n/a | 24 |
| Jan ’25 | CL$129,890.00 | CL$155,370.12 +19.6% | 6.8% | CL$173,938.00 | CL$128,714.12 | n/a | 24 |
| Dec ’24 | CL$129,890.00 | CL$159,847.29 +23.1% | 6.1% | CL$176,440.00 | CL$141,152.00 | n/a | 24 |
| Nov ’24 | CL$153,530.00 | CL$166,133.72 +8.2% | 6.5% | CL$195,086.70 | CL$150,625.08 | CL$146,000.00 | 24 |
| Oct ’24 | CL$153,530.00 | CL$169,528.97 +10.4% | 7.5% | CL$195,912.30 | CL$150,351.30 | CL$146,000.00 | 26 |
| Sep ’24 | CL$124,863.00 | CL$158,161.60 +26.7% | 7.3% | CL$178,235.20 | CL$140,712.00 | CL$146,000.00 | 26 |
| Aug ’24 | CL$124,863.00 | CL$153,928.98 +23.3% | 7.2% | CL$173,641.95 | CL$135,054.85 | CL$146,000.00 | 26 |
| Jul ’24 | CL$124,863.00 | CL$149,122.23 +19.4% | 7.3% | CL$166,868.00 | CL$129,162.25 | CL$147,090.00 | 25 |
| Jun ’24 | CL$124,863.00 | CL$149,752.76 +19.9% | 7.5% | CL$170,246.60 | CL$129,291.05 | CL$147,090.00 | 25 |
| May ’24 | CL$124,863.00 | CL$153,918.66 +23.3% | 9.2% | CL$190,511.00 | CL$129,967.25 | CL$147,090.00 | 27 |
| Apr ’24 | CL$124,863.00 | CL$151,308.90 +21.2% | 9.3% | CL$187,237.68 | CL$127,734.18 | CL$147,090.00 | 28 |
| Mar ’24 | CL$124,863.00 | CL$155,206.70 +24.3% | 9.5% | CL$191,308.68 | CL$120,783.87 | CL$147,090.00 | 28 |
| Feb ’24 | CL$124,863.00 | CL$155,357.23 +24.4% | 9.2% | CL$190,570.00 | CL$120,317.50 | CL$129,890.00 | 28 |
| Jan ’24 | CL$124,863.00 | CL$160,773.65 +28.8% | 9.5% | CL$200,413.56 | CL$126,532.29 | CL$129,890.00 | 28 |
| Dec ’23 | CL$124,863.00 | CL$166,748.93 +33.5% | 9.8% | CL$207,587.96 | CL$125,784.23 | CL$129,890.00 | 28 |
| Nov ’23 | CL$124,863.00 | CL$175,710.21 +40.7% | 10.5% | CL$223,244.20 | CL$135,270.85 | CL$153,530.00 | 28 |
Analyst Forecast: Target price is less than 20% higher than the current share price.